BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8835742)

  • 1. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection.
    Jardi R; Buti M; Rodriguez-Frias F; Cortina M; Esteban R; Guardia J; Pascual C
    J Hepatol; 1996 Jun; 24(6):680-5. PubMed ID: 8835742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.
    Fujiwara K; Yokosuka O; Ehata T; Chuang WL; Imazeki F; Saisho H; Omata M
    Dig Dis Sci; 1998 Feb; 43(2):368-76. PubMed ID: 9512133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Valdes A; Galimany R; Esteban R; Guardia J
    J Viral Hepat; 2001 Nov; 8(6):465-71. PubMed ID: 11703579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of HBeAg/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients.
    Ljunggren KK; Nordenfelt E; Kidd A
    J Med Virol; 1993 Apr; 39(4):297-302. PubMed ID: 8492102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the correlation among quantification of HBV-DNA and HBeAg, anti-HBe in hepatitis B carriers].
    Dou YL; Cheng XQ; Li YZ; Han JH; Ni AP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):709-11. PubMed ID: 17172114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA.
    Jardi R; Rodriguez-Frias F; Buti M; Schaper M; Valdes A; Martinez M; Esteban R; Guardia J
    Hepatology; 2004 Jul; 40(1):133-9. PubMed ID: 15239096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B.
    Costa J; López-Labrador FX; Sánchez-Tapias JM; Mas A; Vilella A; Olmedo E; Vidal J; Jimenez de Anta MT; Rodés J
    J Hepatol; 1995 Jan; 22(1):35-42. PubMed ID: 7751585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
    Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
    World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B.
    Oketani M; Oketani K; Xiaohong C; Arima T
    J Med Virol; 1999 Aug; 58(4):332-7. PubMed ID: 10421398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections.
    Chemin I; Baginski I; Petit MA; Zoulim F; Pichoud C; Capel F; Hantz O; Trepo C
    J Med Virol; 1991 Jan; 33(1):51-7. PubMed ID: 2016601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal emergence of precore mutant hepatitis B virus along with seroconversion to anti-HBe irrespective of subsequent activity of chronic hepatitis B.
    Koh KC; Lee HS; Kim CY
    Korean J Intern Med; 1994 Jul; 9(2):61-6. PubMed ID: 7865490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
    Cabrerizo M; Bartolomé J; Iñigo ER; López-Alcorocho JM; Cotonat T; Carreño V
    J Med Virol; 1998 Dec; 56(4):294-9. PubMed ID: 9829632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative determination of HBV-DNA in chronic hepatitis B: comparison of three methods].
    Jardí R; Buti M; Cotrina M; Rodríguez-Frías F; Costa X; Pascual C; Esteban R; Guardia J
    Gastroenterol Hepatol; 1998; 21(7):327-31. PubMed ID: 9808895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of carriers of hepatitis B virus from a tertiary referral hospital: does the viral load change during the natural course of infection?
    Aakanksha ; Asim M; Sharma PK; Das BC; Kar P
    J Med Virol; 2011 Jul; 83(7):1151-8. PubMed ID: 21520137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers.
    Tedder RS; Ijaz S; Gilbert N; Barbara JA; Corden SA; Gilson RJ; Boxall EH
    J Med Virol; 2002 Dec; 68(4):505-12. PubMed ID: 12376958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of wild-type and e antigen-defective hepatitis B viruses during the course of a short-term corticosteroid therapy in chronic hepatitis B.
    Daikoku M; Nakata K; Hamasaki K; Ido A; Nakao K; Kato Y; Koga M; Yano M; Nagataki S
    J Med Virol; 1995 Oct; 47(2):184-8. PubMed ID: 8830124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays.
    Zampino R; Marrone A; Finnström N; Eriksson T; Törmänen V; Hedrum A; Attanasio V; Rosario P; Utili R; Ruggiero G
    Infez Med; 2005 Jun; 13(2):86-96. PubMed ID: 16220028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.